Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma
Crossref DOI link: https://doi.org/10.1007/s11060-016-2157-2
Published Online: 2016-06-07
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mandel, Jacob J.
Cachia, David
Liu, Diane
Wilson, Charmaine
Aldape, Ken
Fuller, Greg
de Groot, John F.
License valid from 2016-06-07